1. |
Locock C. Discussion. In:Sieveking EH (ed) Analysis of fifty-two cases of epilepsy observed by the author. Med Times Gaz, 1857, 14:524-526.
|
2. |
Gowers WR.Epilepsy and other chronic convulsive disorders.1st ed.London:J&A Churchill,1881.
|
3. |
Duncan S,Read CL,Brodie MJ.How common is catamenial epilepsy?.Epilepsia, 1993, 34(7):827-831.
|
4. |
Herzog AG,Klein P,Ransil BJ.Three patterns of catamenial epilepsy. Epilepsia,1997, 38(11):1082-1088.
|
5. |
Herzog AG.Catamenial epilepsy:definition,prevalence,pathophysiology and treatment.Seizure, 2008, 17(2):151-159.
|
6. |
Ansell B,Clarke E, RosciszewskaD, et al. Ovarian hormones, anticonvulsant drugs and seizures during the menstrual cycle in women with epilepsy.J Neurol Neurosurg Psychiatry, 1986, 49(10):47-51.
|
7. |
Tauboll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res, 1991, 8(3):153-165.
|
8. |
Herzog AG.Catamenial epilepsy:update on prevalence,pathophysiology and treatment from the findings of the NIH progesterone treatment trial. Seizure Eur J Epilepsy, 2015, 24(2):102-104.
|
9. |
Quigg M,Fowler KM,Herzog AG,et al.Circalunar and ultralunar periodicities in women with partial seizures. Epilepsia, 2008, 49(6):1081-1085.
|
10. |
Mattson R,CramerJ,Caldwell B,et al.Treatment of seizures with medroxyprogesteroneacetate:preliminary report.Neurology,1984, 34(7):1255-1258.
|
11. |
Reddy DS, Gould J,Gangisetty O. A mouse kindling model of perimenstrual catamenial epilepsy.J Pharm ExpTherap,2012, 341(3):784-793.
|
12. |
Feely M,Calvert R, J Gibson.Clobazem in catamenial epilepsy:a model for evaluating anticonvulsants.The Lancet,1982, 112(8):71-73.
|
13. |
Navis A, HardenC. A treatment approach to catamenial epilepsy. Curr Treat Options Neurol,2016,Jul;18(7):30.
|
14. |
吴江, 贾建平.神经病学.第3版.北京:人民卫生出版社,2015. 323.
|
15. |
张鲁, 迟兆富.难治性癫痫临床特点及疗效分析[硕士学位论文].济南:山东大学, 2009:1-19.
|